( May 15, 2011) -- Though the FTC concluded that Sanofi-Aventis violated filing requirements of the 2003 Medicare Prescription Drug, Improvement, and Modernization Act (“MMA”), the agency has closed the investigation and offered its reasoning in the case as a guide to the pharmaceutical industry on the MMA’s legal obligations....